Malaria drug resistance under the microscope in ethiopia
NCT ID NCT07527182
First seen Apr 28, 2026 · Last updated May 05, 2026 · Updated 3 times
Summary
This study looked at whether the malaria parasite in Ethiopia is becoming resistant to artemisinin, a key malaria drug. Researchers tested 277 patients across five sites by checking their blood for parasites three days after treatment and analyzing the parasites' genes. The goal was to confirm if drug resistance is present, which helps guide future malaria control efforts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bako Health Center
Bako, Ethiopia
-
Mehoni Health Center
Mersa, Tigray, Ethiopia
-
Metahara Health Center
Metehara, Ethiopia
-
Rama Health Center
Rama, Ethiopia
-
Workamba Health Center
Kechemo, Ethiopia
Conditions
Explore the condition pages connected to this study.